Silk research offers hopes of new treatments

Microscopic versions of the cocoons spun by silkworms have been manufactured by a team of researchers. The capsules, which are invisible to the naked eye, can protect sensitive molecular materials, and could prove a significant...

Nasal sprays – Key insights for a successful device development to achieve bioequivalence requirements

An observation of generics in the nasal spray market will reveal to the keen observer an opportunity. Whilst the overall nasal spray market is currently experiencing limited growth, the market share of generics is...

UK adults differ from NHS England boss on health priorities

A recent poll shows UK adults believe dementia is in the top three health areas the NHS should focus on in the next 10 years. The survey commissioned by Alzheimer’s Research UK shows starkly...

Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms

A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time. A UCL-led team of international scientists have built on...

AI approach outperformed human experts in identifying cervical pre-cancer

Algorithm could revolutionize cervical cancer screening, especially in low-resource settings. A research team led by investigators from the National Institutes of Health and Global Good has developed a computer algorithm that can analyze digital images...

New material to treat wounds can protect against resistant bacteria

Researchers at Chalmers University of Technology, Sweden, have developed a new material that prevents infections in wounds – a specially designed hydrogel, that works against all types of bacteria, including antibiotic-resistant ones. The new...

anti-cancer compound discovered in the humble willow

Scientists led from Rothamsted Research, working with cancer biologists at the University of Kent have discovered the chemical, miyabeacin, which has been found to kill various cancer cells, including those resistant to other drugs. Of...

IBM releases novel AI-powered technology to accelerate medical research for COVID-19

IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery. These novel resources, from across IBM and available beginning today (Friday 3 April)...

High levels of scarlet fever remain across England

Public Health England (PHE) has reported a continuation of the high levels of scarlet fever across the country with 405 new cases reported in the last week (from 21 to 27 April). A total...

FREE WEBINAR ANNOUNCED IN ADAPTATION TO CLIMATE CHANGE

Climate resilience experts, Climate Sense, and water industry training provider, Learning & Development Associates (L&DA), have announced a free webinar on adaptation to climate change following the launch of their new qualifications. The first step...

Artificial heart is successfully implanted

A bioprosthetic artificial heart has been implanted in a critically ill patient for only the third time ever in a commercial setting. The Aeson® device – heralded as the world’s most advanced total artificial heart...

Testosterone levels affect risk of metabolic disease and cancers

Having genetically higher testosterone levels increases the risk of metabolic diseases such as type 2 diabetes in women, while reducing the risk in men. Higher testosterone levels also increase the risks of breast and...

Research centres are confirmed

Two Cambridge institutes have been confirmed as major research centres by biomedical research charity Wellcome. The Wellcome/CRUK Gurdon Institute and Wellcome/MRC Cambridge Stem Cell Institute have been named as two of 14 Wellcome Centres which...

Rheumatology drugs study

Researchers at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath, part of the Royal United Hospitals Bath NHS Foundation Trust, are celebrating recruiting the first patient globally to an international study that...

UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S....

London, and New York, NY, 21 July 2020 – UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company,...

Flu vaccine programme has impact

Early results from the 2013 to 2014 child flu vaccine pilot programme suggest a positive impact on levels of flu in the United Kingdom. Public Health England (PHE), which launched the pilot programme last year,...